Professor David H. Vesole, MD, PhD, FACP is Co-Chief, Myeloma Division, Director, Myeloma Research at the John Theurer Cancer Center
at Hackensack UMC; Professor of Medicine at Georgetown University School of Medicine and HackensackMeridian School of Medicine;
Director, Myeloma Program, Medstar Georgetown UniversityHospital. He is a Member of the Stem Cell Transplant & Cellular
Immunotherapy Programat both Hackensack UMC and Medstar Georgetown University Hospital.
Dr. Vesole’s research interests involve all aspects of the management of plasma cell dyscrasias (multiple myeloma, monoclonal gammopathy
of undetermined significance,amyloidosis, Waldenstrom’s macroglolinemia).
Dr. Vesole has had more than 30 yearsof clinical research experience in plasma cell dyscrasias, stem cell transplant and noweffector cell therapy: he has over 250 peer reviewed publications in these areas.He is a member of the International Myeloma Working Group and listedin the IWMF Directory of WM Physicians.
Dr. Vesole earned his bachelor of sciences degree at the University of Iowa; PhDdegree in Immunology and Microbiology at the Medical University of South Carolina,his medical degree at Northwestern University and completed his hematology/oncologyfellowship at the University of Iowa
